Nagy E V, Burch H B, Lukes Y G, Carr F E, Kosugi S, Kohn L D, Burman K D
Department of Clinical Investigation and Medicine, Walter Reed Army Medical Center, Washington, DC 20307-5001.
J Endocrinol Invest. 1993 Jul-Aug;16(7):485-93. doi: 10.1007/BF03348887.
Clarifying the role of the TSH receptor protein in the autoimmune process may be the key to understanding the development of Graves' disease. In the present study we used a 16 amino acid peptide of the human TSH receptor (hTSHR) to immunize rabbits. A comparable, but theoretically less immunogenic, peptide was injected into other rabbits. The antibody response against these and other peptides, as well as against solubilized human thyroid membrane (TM) and guinea pig fat cell membrane (GPF) proteins, was tested using ELISA and Western blots. The GPF and TM binding pattern of rabbits' sera was compared to that of Graves' patients' sera. We have identified an area of antigenic cross-reactivity between GPF and TM; a 63 kD protein was present in both GPF and TM, and this protein uniformly bound IgG-s of the rabbits' postimmunization sera and one of eight Graves' patient's serum. We have shown that i) a theoretically immunogenic 16 amino acid peptide was indeed highly immunogenic in rabbits, ii) antibodies binding to GPF and TM were detected after immunization, and iii) the peak of thyroid stimulating immunoglobulin activity of sera was followed by a transient elevation of serum triiodothyronine levels. Further studies investigating the immunogenic epitopes of the hTSHR as well as characterizing the 63 kD protein are indicated.
阐明促甲状腺激素受体蛋白在自身免疫过程中的作用可能是理解格雷夫斯病发病机制的关键。在本研究中,我们用人促甲状腺激素受体(hTSHR)的一段16个氨基酸的肽段免疫兔子。将一段类似但理论上免疫原性较低的肽段注射到其他兔子体内。使用酶联免疫吸附测定(ELISA)和蛋白质免疫印迹法检测兔子对这些肽段和其他肽段以及对可溶性人甲状腺膜(TM)和豚鼠脂肪细胞膜(GPF)蛋白的抗体反应。将兔子血清的GPF和TM结合模式与格雷夫斯病患者血清的结合模式进行比较。我们确定了GPF和TM之间存在抗原交叉反应区域;一种63kD的蛋白同时存在于GPF和TM中,并且这种蛋白能与兔子免疫后血清和8例格雷夫斯病患者血清中的1例血清中的IgG均匀结合。我们已经表明:i)一段理论上具有免疫原性的16个氨基酸的肽段在兔子中确实具有高度免疫原性;ii)免疫后检测到了与GPF和TM结合的抗体;iii)血清中甲状腺刺激免疫球蛋白活性达到峰值后,血清三碘甲状腺原氨酸水平出现短暂升高。有必要进一步研究hTSHR的免疫原性表位以及对63kD蛋白进行特性鉴定。